A 55-year-old man presents to the emergency department with several months of intermittent epigastric pain. The pain improves shortly after eating but recurs several hours later and occasionally awakens him from sleep. He does not use nonsteroidal anti-inflammatory drugs. Past medical history is significant for hyperlipidemia which is treated with atorvastatin. Vital signs are within normal limits. Physical examination reveals mild midepigastric abdominal tenderness to palpation without guarding or rebound. Upper endoscopy reveals a duodenal ulcer, and testing confirms Helicobacter pylori infection.
Which of the following is the most appropriate treatment?
The correct answer is:
A) Bismuth subsalicylate, metronidazole, tetracycline, and a proton pump inhibitor
This patient has H. pylori-associated duodenal ulcer disease. Current treatment recommendations favor bismuth quadruple therapy because it effectively eradicates H. pylori while avoiding concerns about increasing antibiotic resistance with other treatment regimens. Repeat H. pylori testing after 4 weeks is recommended to confirm successful treatment. Eradication promotes ulcer healing and substantially reduces recurrence rates.
Answer choice B: Ciprofloxacin and metronidazole, is incorrect. This regimen is not a recommended first-line treatment and has not demonstrated the efficacy of established eradication protocols. Appropriate treatment requires a validated multidrug regimen.
Answer choice C: Omeprazole alone, is incorrect. A proton pump inhibitor will reduce gastric acid secretion and may improve symptoms temporarily. However, it does not eliminate H. pylori, allowing the underlying infection to persist. This answer would be more appropriate for uncomplicated dyspepsia without evidence of H. pylori infection.
Answer choice D: Prednisone and omeprazole, is incorrect. Prednisone has no therapeutic role in H. pylori-associated peptic ulcer disease and may actually increase the risk of gastrointestinal complications.
Answer choice E: Sucralfate alone, is incorrect. Sucralfate can coat the ulcer base and promote healing, making it a tempting option. However, like proton pump inhibitor monotherapy, it does not eradicate H. pylori. It may be used as adjunctive therapy for an ulcer but is not sufficient as definitive treatment.
Key Learning Point
Peptic ulcers caused by H. pylori require eradication therapy because acid suppression alone does not eliminate the underlying infection. The current preferred regiment according to the American College of Gastroenterology guidelines is 14 days of bismuth subsalicylate or subcitrate, a proton pump inhibitor, metronidazole, and tetracycline.
